Literature DB >> 10631949

Peptide exchange in MHC molecules.

P E Jensen1, D A Weber, W P Thayer, L E Westerman, C T Dao.   

Abstract

Major histocompatibility complex (MHC)-encoded glycoproteins bind peptide antigens through non-covalent interactions to generate complexes that are displayed on the surface of antigen-presenting cells (APC) for recognition by T cells. Peptide-binding site occupancy is necessary for stable assembly of newly synthesized MHC proteins and export from the endoplasmic reticulum (ER). The MHC class II antigen-processing pathway provides a mechanism for presentation of peptides generated in the endosomal pathway of APC. The chaperone protein, invariant chain, includes a surrogate peptide that stabilizes newly synthesized class II molecules during transport to endosomal compartments. The invariant chain-derived peptide must be replaced through a peptide exchange reaction that is promoted by acidic pH and the MHC-encoded co-factor HLA-DM. Peptide exchange reactions are not required for presentation of antigens by MHC class I molecules because they bind antigens during initial assembly in the ER. However, exchange reactions may play an important role in editing the repertoire of peptides presented by both class II and class I molecules, thus influencing the specificity of immunity and tolerance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10631949     DOI: 10.1111/j.1600-065x.1999.tb01368.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  17 in total

1.  Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing.

Authors:  S Surman; T D Lockey; K S Slobod; B Jones; J M Riberdy; S W White; P C Doherty; J L Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

Review 2.  The expression of HLA-DO (H2-O) in B lymphocytes.

Authors:  Xinjian Chen; Peter E Jensen
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells.

Authors:  Alexei von Delwig; Julie A Musson; Joe Gray; Norman McKie; John H Robinson
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

4.  Ligand design by a combinatorial approach based on modeling and experiment: application to HLA-DR4.

Authors:  Erik Evensen; Diane Joseph-McCarthy; Gregory A Weiss; Stuart L Schreiber; Martin Karplus
Journal:  J Comput Aided Mol Des       Date:  2007-07-27       Impact factor: 3.686

5.  A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules.

Authors:  Olaf Rötzschke; Julie M Lau; Maria Hofstätter; Kirsten Falk; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-05       Impact factor: 11.205

Review 6.  Biomolecular cytokine therapy.

Authors:  Márta Bencsáth; Aladár Blaskovits; János Borvendég
Journal:  Pathol Oncol Res       Date:  2003-04-18       Impact factor: 3.201

7.  Identification of the transcriptional response of human intestinal mucosa to Lactobacillus plantarum WCFS1 in vivo.

Authors:  Freddy J Troost; Peter van Baarlen; Patrick Lindsey; Andrea Kodde; Willem M de Vos; Michiel Kleerebezem; Robert-Jan M Brummer
Journal:  BMC Genomics       Date:  2008-08-05       Impact factor: 3.969

8.  Identification of an I-Ed-restricted T-cell epitope of Escherichia coli outer membrane protein F.

Authors:  Kristina M Williams; Elmer C Bigley
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

Review 9.  Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases?

Authors:  Philippa Marrack; John W Kappler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-09-01       Impact factor: 6.915

10.  Oxidative stress impairs intracellular events involved in antigen processing and presentation to T cells.

Authors:  Olivier Preynat-Seauve; Sylvia Coudurier; Alain Favier; Patrice-Noël Marche; Christian Villiers
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.